-------------------------------------------------------------------------------------------------------------------------------------------

"New compound(s): Milestone slide had the box checked off for "Confirm a second clinical compound IND candidate" with the added comment "Seven compounds chosen for follow-on testing." 2400 synthesized compounds in library. RVX-206, RVX-641, RVX-2101, RVX-2113 (Just happen to be 4 of DM’s favorites). Complement, Calciphylaxis, Autoimmune, FSHD/DMD, Pulmonary."

-------------------------------------------------------------------------------------------------------------------------------------------

Yes,,,exactly,,,,,,,,,,,,sell a couple of these molecules to an entity who can actually get it or them into trial asap,,and reap the benefit of having some upfront cash to work with for the BoM2,,,,,and then perhaps sell a few more to finance BoM3,,,and,,,,,so on and so on,,,,

Rockabye baby on the tree top,,,,play it again Sam!!!!